Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
2021 · Nature · 2,151 citations
https://doi.org/10.1038/s41586-021-03777-9
C
Cyril Planchais
Institut Pasteur(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
98
Papers
9.1K
Citations
31
h-index
62
i10-index
Cyril Planchais is an academic researcher from Institut Pasteur. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Immune Cell Function and Interaction. The author has an h-index of 31, co-authored 84 publications.
ORCID: 0000-0002-5142-7253Papers by this author
worksConsiderable escape of SARS-CoV-2 Omicron to antibody neutralization
2021 · Nature · 1,586 citations
https://doi.org/10.1038/s41586-021-04389-z
Syncytia formation by SARS‐CoV‐2‐infected cells
2020 · The EMBO Journal · 494 citations
https://doi.org/10.15252/embj.2020106267
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
2023 · Nature Communications · 195 citations
https://doi.org/10.1038/s41467-023-36561-6
TMPRSS2 is a functional receptor for human coronavirus HKU1
2023 · Nature · 102 citations
https://doi.org/10.1038/s41586-023-06761-7
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies
2021 · Cell Reports Medicine · 92 citations
https://doi.org/10.1016/j.xcrm.2021.100275
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat